VLTO Q1 2026 Earnings EPS Beat of 435 Despite Stock Decline CGON Q1 2026 Earnings EPS Miss as ClinicalStage Oncology Firm Reports No Revenue HSTM Q1 2026 Earnings EPS Surpasses Estimates by Over 21 INCR Q2 2023 Earnings EPS Surges Past Estimates as Profitability Strengthens Vaxcyte Q1 2026 Earnings EPS Misses Estimates Amid PreCommercial Investment Phase Immunome Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Declines